SOCS3 and lung carcinoma: Although various oncogenic targets as discussed above have been described to account for the potent anticancer activities of BSN, our study is the first one to explore the effects of BSN both on STAT3 signaling pathway and on the negative regulators of STAT3 signaling (PIAS-3 and SOCS-3) in human lung carcinoma.